Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21527 | 358 | 34.5 | 72% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 812 | 11335 | CANDIDA ALBICANS//CANDIDA DUBLINIENSIS//CANDIDA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SACCHAROMYCES BOULARDII | Author keyword | 53 | 47% | 23% | 82 |
| 2 | BIOTHERAPEUTIC AGENT | Author keyword | 3 | 50% | 1% | 4 |
| 3 | SACCHAROMYCES CEREVISIAE VAR BOULARDII | Author keyword | 2 | 67% | 1% | 2 |
| 4 | CLINICAL STRAINS | Author keyword | 2 | 24% | 2% | 6 |
| 5 | GASTROINTESTINAL KINETICS | Author keyword | 1 | 100% | 1% | 2 |
| 6 | LESAFFRE FEED ADDIT | Address | 1 | 100% | 1% | 2 |
| 7 | PIG JEJUNUM | Author keyword | 1 | 50% | 1% | 2 |
| 8 | S CEREVISIAE VAR BOULARDII | Author keyword | 1 | 100% | 1% | 2 |
| 9 | SECT INFLAMMATORY BOWEL DIS | Address | 1 | 50% | 1% | 2 |
| 10 | TEAM INFLAMMAT CANC CANC STEM CELLS 4 | Address | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SACCHAROMYCES BOULARDII | 53 | 47% | 23% | 82 | Search SACCHAROMYCES+BOULARDII | Search SACCHAROMYCES+BOULARDII |
| 2 | BIOTHERAPEUTIC AGENT | 3 | 50% | 1% | 4 | Search BIOTHERAPEUTIC+AGENT | Search BIOTHERAPEUTIC+AGENT |
| 3 | SACCHAROMYCES CEREVISIAE VAR BOULARDII | 2 | 67% | 1% | 2 | Search SACCHAROMYCES+CEREVISIAE+VAR+BOULARDII | Search SACCHAROMYCES+CEREVISIAE+VAR+BOULARDII |
| 4 | CLINICAL STRAINS | 2 | 24% | 2% | 6 | Search CLINICAL+STRAINS | Search CLINICAL+STRAINS |
| 5 | GASTROINTESTINAL KINETICS | 1 | 100% | 1% | 2 | Search GASTROINTESTINAL+KINETICS | Search GASTROINTESTINAL+KINETICS |
| 6 | PIG JEJUNUM | 1 | 50% | 1% | 2 | Search PIG+JEJUNUM | Search PIG+JEJUNUM |
| 7 | S CEREVISIAE VAR BOULARDII | 1 | 100% | 1% | 2 | Search S+CEREVISIAE+VAR+BOULARDII | Search S+CEREVISIAE+VAR+BOULARDII |
| 8 | A AGGLUTININ | 1 | 50% | 0% | 1 | Search A+AGGLUTININ | Search A+AGGLUTININ |
| 9 | ALTERED HABITAT | 1 | 50% | 0% | 1 | Search ALTERED+HABITAT | Search ALTERED+HABITAT |
| 10 | ANTARCTIC EXPEDITION | 1 | 50% | 0% | 1 | Search ANTARCTIC+EXPEDITION | Search ANTARCTIC+EXPEDITION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BOULARDII | 23 | 47% | 10% | 36 |
| 2 | INFECTED T84 CELLS | 15 | 82% | 3% | 9 |
| 3 | BOULARDII FUNGEMIA | 9 | 67% | 2% | 8 |
| 4 | ENDOLUMINAL RELEASE | 8 | 75% | 2% | 6 |
| 5 | CLOSTRIDIUM DIFFICILE DISEASE | 6 | 25% | 5% | 19 |
| 6 | CEREVISIAE FUNGEMIA | 6 | 100% | 1% | 4 |
| 7 | INDUCED MORTALITY | 4 | 20% | 5% | 19 |
| 8 | GNOTOBIOTIC MICE | 4 | 14% | 8% | 27 |
| 9 | T84 CELLS | 3 | 14% | 5% | 18 |
| 10 | BIOTHERAPEUTIC AGENTS | 3 | 35% | 2% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders | 2012 | 15 | 112 | 58% |
| Invasive Saccharomyces infection: A comprehensive review | 2005 | 97 | 72 | 71% |
| Yeast as probiotics - Saccharomyces boulardii | 2007 | 92 | 61 | 57% |
| Experimental effects of Saccharomyces boulardii on diarrheal pathogens | 2002 | 70 | 36 | 72% |
| Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and Perspectives | 2009 | 26 | 38 | 53% |
| Saccharomyces cerevisiae fungemia in a head and neck cancer patient: A case report and review of the literature | 2004 | 12 | 17 | 88% |
| Saccharomyces boulardii in childhood | 2009 | 20 | 74 | 50% |
| Saccharomyces boulardii effects on gastrointestinal diseases | 2009 | 23 | 86 | 45% |
| Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii | 2009 | 36 | 49 | 33% |
| Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease | 2015 | 2 | 72 | 15% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LESAFFRE FEED ADDIT | 1 | 100% | 0.6% | 2 |
| 2 | SECT INFLAMMATORY BOWEL DIS | 1 | 50% | 0.6% | 2 |
| 3 | TEAM INFLAMMAT CANC CANC STEM CELLS 4 | 1 | 100% | 0.6% | 2 |
| 4 | USC INRA ECOSYST MICROBIEN DIGESTIF SANTE | 1 | 40% | 0.6% | 2 |
| 5 | NUCLEO PESQUISA POS | 1 | 33% | 0.6% | 2 |
| 6 | UNIT PEDIAT | 1 | 23% | 0.8% | 3 |
| 7 | ACTIVAT CELLULES HEMATOPOIET U526 | 1 | 50% | 0.3% | 1 |
| 8 | CHARITE MED MED GASTROENTEROL HEPA | 1 | 50% | 0.3% | 1 |
| 9 | EA CELLULES DENDRIT GREFFES 4245 | 1 | 50% | 0.3% | 1 |
| 10 | INFECT DIS SUSCEPTIBIL PROGRAM | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000245317 | PROBIOTICS//ESCHERICHIA COLI NISSLE 1917//LACTOBACILLUS GG |
| 2 | 0.0000224433 | CANDIDA PELLICULOSA//KODAMAEA OHMERI//HANSENULA ANOMALA |
| 3 | 0.0000153982 | NITROXOLINE//NEWBORNS AT RISK//MYCOPHOBIA |
| 4 | 0.0000116427 | LG21//MUSCADINE GRAPE SKIN//SECT BIOMEMBRANES |
| 5 | 0.0000093806 | CLOSTRIDIUM SORDELLII//TOXIN A//CLOSTRIDIUM DIFFICILE TOXIN A |
| 6 | 0.0000080914 | NON SACCHAROMYCES//BRETTANOMYCES//DEKKERA |
| 7 | 0.0000080699 | SEGMENTED FILAMENTOUS BACTERIA//CANDIDATUS ARTHROMITUS//PUTREFACTIVE PRODUCTS |
| 8 | 0.0000075271 | CLOSTRIDIUM DIFFICILE//CLOSTRIDIUM DIFFICILE INFECTION//PSEUDOMEMBRANOUS COLITIS |
| 9 | 0.0000071572 | FLO11//FLO1//FLO GENES |
| 10 | 0.0000067961 | TETW//IDENTIFICAT SECT//LACTOBACILLEMIA |